Matrix metalloproteinases collagenase-2, macrophage elastase, collagenase-3, and membrane type 1-matrix metalloproteinase impair clotting by degradation of fibrinogen and factor XII

Hiller O, Lichte A, Oberpichler A, Kocourek A, Tschesche H (2000)
JOURNAL OF BIOLOGICAL CHEMISTRY 275(42): 33008-33013.

Download
No fulltext has been uploaded. References only!
Journal Article | Original Article | Published | English

No fulltext has been uploaded

Author
; ; ; ;
Abstract
The effects of plasma proteins on controlling the activity of matrix metalloproteinases (MMPs, matrixins) have been the focus of numerous studies, although only a few have examined the influence of matrixins on plasma proteins. Recently, it has been shown that MMPs may play a role in the degradation of fibrin, We have now investigated the role of collagenase-a (MMP-8), macrophage elastase (MMP-12), collagenase-3 (MMP-13), and membrane type 1-matrix metalloproteinase (MT1-MMP, MMMP-14) in the degradation of fibrinogen and Factor XII of the plasma clotting system. Our data demonstrate that the catalytic domains of MMP-8, MMP-12, MMP-13, and MMP-14 can proteolytically process fibrinogen and, with the exception of MMP-8, also inactivate Factor XII (Hageman factor). We have identified the amino termini of the major protein fragments. Cleavage of fibrinogen occurred in all chains and resulted in significantly impaired clotting. Moreover, rapid proteolytic inactivation of Factor XII (Hageman factor) by MMP-18, MMP-13, and MMP-14 was noted. These results support the hypothesis of an impaired thrombolytic potential of MMP-degraded Factor MI in vivo. MMP-induced degradation of fibrinogen supports a plasmin-independent fibrinolysis mechanism. Consequently, degradation of these proteins may be important in inflammation, atherosclerosis, and angiogenesis, all of which are known to be influenced by MMP activity.
Publishing Year
ISSN
PUB-ID

Cite this

Hiller O, Lichte A, Oberpichler A, Kocourek A, Tschesche H. Matrix metalloproteinases collagenase-2, macrophage elastase, collagenase-3, and membrane type 1-matrix metalloproteinase impair clotting by degradation of fibrinogen and factor XII. JOURNAL OF BIOLOGICAL CHEMISTRY. 2000;275(42):33008-33013.
Hiller, O., Lichte, A., Oberpichler, A., Kocourek, A., & Tschesche, H. (2000). Matrix metalloproteinases collagenase-2, macrophage elastase, collagenase-3, and membrane type 1-matrix metalloproteinase impair clotting by degradation of fibrinogen and factor XII. JOURNAL OF BIOLOGICAL CHEMISTRY, 275(42), 33008-33013. doi:10.1074/jbc.M001836200
Hiller, O., Lichte, A., Oberpichler, A., Kocourek, A., and Tschesche, H. (2000). Matrix metalloproteinases collagenase-2, macrophage elastase, collagenase-3, and membrane type 1-matrix metalloproteinase impair clotting by degradation of fibrinogen and factor XII. JOURNAL OF BIOLOGICAL CHEMISTRY 275, 33008-33013.
Hiller, O., et al., 2000. Matrix metalloproteinases collagenase-2, macrophage elastase, collagenase-3, and membrane type 1-matrix metalloproteinase impair clotting by degradation of fibrinogen and factor XII. JOURNAL OF BIOLOGICAL CHEMISTRY, 275(42), p 33008-33013.
O. Hiller, et al., “Matrix metalloproteinases collagenase-2, macrophage elastase, collagenase-3, and membrane type 1-matrix metalloproteinase impair clotting by degradation of fibrinogen and factor XII”, JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 275, 2000, pp. 33008-33013.
Hiller, O., Lichte, A., Oberpichler, A., Kocourek, A., Tschesche, H.: Matrix metalloproteinases collagenase-2, macrophage elastase, collagenase-3, and membrane type 1-matrix metalloproteinase impair clotting by degradation of fibrinogen and factor XII. JOURNAL OF BIOLOGICAL CHEMISTRY. 275, 33008-33013 (2000).
Hiller, O, Lichte, A, Oberpichler, A, Kocourek, A, and Tschesche, Harald. “Matrix metalloproteinases collagenase-2, macrophage elastase, collagenase-3, and membrane type 1-matrix metalloproteinase impair clotting by degradation of fibrinogen and factor XII”. JOURNAL OF BIOLOGICAL CHEMISTRY 275.42 (2000): 33008-33013.
This data publication is cited in the following publications:
This publication cites the following data publications:

58 Citations in Europe PMC

Data provided by Europe PubMed Central.

Deficiency of cathepsin S reduces atherosclerosis in LDL receptor-deficient mice.
Sukhova GK, Zhang Y, Pan JH, Wada Y, Yamamoto T, Naito M, Kodama T, Tsimikas S, Witztum JL, Lu ML, Sakara Y, Chin MT, Libby P, Shi GP., J Clin Invest 111(6), 2003
PMID: 12639996
Matrix metalloproteinases (MMPs) regulate fibrin-invasive activity via MT1-MMP-dependent and -independent processes.
Hotary KB, Yana I, Sabeh F, Li XY, Holmbeck K, Birkedal-Hansen H, Allen ED, Hiraoka N, Weiss SJ., J Exp Med 195(3), 2002
PMID: 11828004
Matrix metalloproteinase inhibitors: do they have a place in anticancer therapy?
Rudek MA, Venitz J, Figg WD., Pharmacotherapy 22(6), 2002
PMID: 12066962
How matrix metalloproteinases regulate cell behavior.
Sternlicht MD, Werb Z., Annu Rev Cell Dev Biol 17(), 2001
PMID: 11687497
Substrate specificity determinants of human macrophage elastase (MMP-12) based on the 1.1 A crystal structure.
Lang R, Kocourek A, Braun M, Tschesche H, Huber R, Bode W, Maskos K., J Mol Biol 312(4), 2001
PMID: 11575928

Export

0 Marked Publications

Open Data PUB

Web of Science

View record in Web of Science®

Sources

PMID: 10930399
PubMed | Europe PMC

Search this title in

Google Scholar